Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Drug Delivery

News in brief

Prokarium to create new oral vaccine delivery tech

10-Jul-2012

Prokarium – a biotech company that was formerly part of UK CMO Cobra Biologics spin-out - has bought an oral vaccine technology from Emergent BioSolutions.

The platform includes is a live Salmonella-based typhoid vaccine Typhella and genetic technology spi-VEC developed by Emergent. Prokarium will combine this with its own ORT-vac expression platform to create an oral vaccine delivery platform, named Vaxonella.

Prokarium plans to license the delivery platform to other biotechnology companies, while its in-house team will use it to develop a dual oral vaccine against typhoid and travellers’ diarrhoea.

Key Industry Events

Interphex 2014

New York, NY 10001 / Conference and exhibition

Read more

Access all events listing